CADENCE CAPITAL MANAGEMENT LLC - ANACOR PHARMACEUTICALS INC ownership

ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 174 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.

Quarter-by-quarter ownership
CADENCE CAPITAL MANAGEMENT LLC ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$641,000
-51.2%
5,670
-75.0%
0.04%
-46.2%
Q1 2015$1,314,000
+140.7%
22,710
+34.1%
0.08%
+150.0%
Q4 2014$546,00016,9300.03%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$125,702,00041.75%
VHCP Management, LLC 1,178,474$138,718,00035.56%
Palo Alto Investors LP 2,579,154$303,592,00014.60%
Baker Brothers Advisors 4,135,412$486,779,0004.50%
APIS CAPITAL ADVISORS, LLC 23,000$2,708,0003.75%
EMORY UNIVERSITY 11,096$1,306,0003.64%
Atika Capital Management LLC 61,000$7,180,0003.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 488,912$57,550,0002.78%
Segantii Capital Management Ltd 100,000$11,134,0002.55%
NEXT CENTURY GROWTH INVESTORS LLC 428,835$50,478,0002.10%
View complete list of ANACOR PHARMACEUTICALS INC shareholders